The primary objective is to confirm the target receptor occupancy of SK-1405 and to correlate receptor occupancy with SK-1405 dose and plasma concentration. The secondary objective is to assess the safety and tolerability of SK-1405 in healthy, Caucasian, male subjects.
Study Type
INTERVENTIONAL
Purpose
TREATMENT
Hammersmith Medicines Research
London, London, United Kingdom
The receptor occupancy of SK-1405 as measured by PET-CT imaging with [11C]-carfentanil
Time frame: up to 4 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.